Toward a network model of MHC class II-restricted antigen processing

Frontiers in Immunology

Volumn 4, Issue DEC, 2013, Pages

  Miller, Michael A ^a   Ganesan, Asha Purnima V ^a   Eisenlohr, Laurence C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Alternative processing; Antigen presentation; Antigen processing; Endogenous; MHC class II; Review

Indexed keywords

EID: 84892141576     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00464     Document Type: Short Survey

References (147)

1. Silverstein AM. A History of Immunology. San Diego: Academic Press (1989).
2. Gell PGH, Benacerraf B. Studies on hypersensitivity. II. Delayed hypersensitivity to denatured proteins in guinea pigs. Immunology (1959) 2:64-70.
3. Kantor FS, Ojeda A, Benacerraf B. Studies of artificial antigens I. Antigenicity of DNP-polylysine and DNP copolymer of lysine and glutamic acid in guinea pigs. J Exp Med (1963) 117:55-69. doi: 10.1084/jem.117.1.55
4. Vadas MA, Miller JF, McKenzie IF, Chism SE, Shen FW, Boyse EA, et al. Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 144:10-9. doi:10.1084/jem.144.1.10
5. Shevach EM, Rosenthal AS. Function of macrophages in antigen recognition by guinea pig T lymphocytes. II. Role of the macrophage in the regulation of genetic control of the immune response. J Exp Med (1973) 138:1213-29. doi:10.1084/jem.138.5.1213
6. Waldron JA, Horn RG, Rosenthal AS. Antigen-induced proliferation of guinea pig lymphocytes in vitro: obligatory role of macrophages in the recognition of antigen by immune T-lymphocytes. J Immunol (1973) 111:58-64.
7. Rosenthal AS. Determinant selection and macrophage function in genetic control of the immune response. Immunol Rev (1978) 40:135-52. doi:10.1111/j.1600-065X.1978.tb00404.x
8. Ziegler K, Unanue ER. Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. J Immunol (1981) 127:1869-75.
9. Ziegler HK, Unanue ER. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A (1982) 79:175-8. doi:10.1073/pnas.79.1.175
10. Ziegler K, Unanue ER. The specific binding of Listeria monocytogenes-immune T lymphocytes to macrophages. I. Quantitation and role of H-2 gene products. J Exp Med (1979) 150:1143-60. doi:10.1084/jem.150.5.1143
11. Shimonkevitz R, Kappler J, Marrack P, Grey H. Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J Exp Med (1983) 158:303-16. doi:10.1084/jem.158.2.303
12. Allen PM, Strydom DJ, Unanue ER. Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas. Proc Natl Acad Sci U S A (1984) 81:2489-93. doi:10.1073/pnas.81.8.2489
13. Babbitt BP, Allen PM, Matsueda GR, Haber E, Unanue ER. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature (1985) 317:359-61. doi:10.1038/317359a0
14. Allen PM, Matsueda GR, Evans RJ, Dunbar JB Jr, Marshall GR, Unanue ER. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope. Nature (1987) 327:713-5. doi:10.1038/327713a0
15. Takahashi H, Cease KB, Berzofsky JA. Identification of proteases that process distinct epitopes on the same protein. J Immunol (1989) 142:2221-9.
16. van Noort JM, Boon J, Van Der Drift ACM, Wagenaar JPA, Boots AMH, Boog CJP. Antigen processing by endosomal proteases determines which sites of sperm-whale myoglobin are eventually recognized by T cells. Eur J Immunol (1991) 21:1989-96. doi:10.1002/eji.1830210904
17. Bennett K, Levine T, Ellis JS, Peanasky RJ, Samloff IM, Kay J, et al. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur J Immunol (1992) 22:1519-24. doi:10.1002/eji.1830220626
18. Williams KP, Smith JA. Isolation of a membrane-associated cathepsin D-like enzyme from the model antigen presenting cell, A20, and its ability to generate antigenic fragments from a protein antigen in a cell-free system. Arch Biochem Biophys (1993) 305:298-306. doi:10.1006/abbi.1993.1426
19. Manoury B, Hewitt EW, Morrice N, Dando PM, Barrett AJ, Watts C. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature (1998) 396:695-9. doi:10.1038/25379
20. Chesnut RW, Grey HM. Studies on the capacity of B cells to serve as antigen-presenting cells. J Immunol (1981) 126:1075-9.
21. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature (1985) 314:537-9. doi:10.1038/314537a0
22. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med (1995) 1957:1963.
23. Sunshine GH, Gold DP, Wortis HH, Marrack P, Kappler JW. Mouse spleen dendritic cells present soluble antigens to antigen-specific T cell hybridomas. J Exp Med (1983) 158:1745-50. doi:10.1084/jem.158.5.1745
24. Van Voorhis WC, Valinsky J, Hoffman E, Luban J, Hair LS, Steinman RM. Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication. J Exp Med (1983) 158:174-91. doi:10.1084/jem.158.1.174
25. Fling SP, Arp B, Pious D. HLA-DMA and-DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature (1994) 368:554-8. doi:10.1038/368554a0
26. Morris P, Shaman J, Attaya M, Amaya M, Goodman S, Bergman C, et al. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature (1994) 368:551-4. doi:10.1038/368551a0
27. Bakke O, Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell (1990) 63:707-16. doi:10.1016/0092-8674(90)90137-4
28. Marks MS, Blum JS, Cresswell P. Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J Cell Biol (1990) 111:839-55. doi:10.1083/jcb.111.3.839
29. Peterson M, Miller J. Invariant chain influences the immunological recognition of MHC class II molecules. Nature (1990) 345:172-4. doi:10.1038/345172a0
30. Roche PA, Cresswell P. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature (1990) 345:615-8. doi:10.1038/345615a0
31. Teyton L, O'Sullivan D, Dickson PW, Lotteau V, Sette A, Fink P, et al. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature (1990) 348:39-44. doi:10.1038/348039a0
32. Roche PA, Marks MS, Cresswell P. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature (1991) 354:392-4. doi:10.1038/354392a0
33. Cresswell P. Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol (1994) 12:259-93. doi:10.1146/annurev.iy.12.040194.001355
34. Cresswell P. Invariant chain structure and MHC class II function. Cell (1996) 84:505-7. doi:10.1016/S0092-8674(00)81025-9
35. Germain RN, Hendrix LR. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature (1991) 353:134-9. doi:10.1038/353134a0
36. Sadegh-Nasseri S, Germain RN. A role for peptide in determining MHC class II structure. Nature (1991) 353:167-70. doi:10.1038/353167a0
37. Amigorena S, Drake JR, Webster P, Mellman I. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature (1994) 369:113-20. doi:10.1038/369113a0
38. Qui Y, Xu X, Wandinger-Ness A, Dalke DP, Pierce SK. Separation of subcellular compartments containing distinct functional forms of MHC class II. J Cell Biol (1994) 125:595-605. doi:10.1083/jcb.125.3.595
39. Tulp A, Verwoerd D, Dobberstein B, Ploegh HL, Pieters J. Isolation and characterization of the intracellular MHC class II compartment. Nature (1994) 369:120-6. doi:10.1038/369120a0
40. West MA, Lucocq JM, Watts C. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature (1994) 369:147-51. doi:10.1038/369147a0
41. Pious D, Dixon L, Levine F, Cotner T, Johnson R. HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants. J Exp Med (1985) 162:1193-207. doi:10.1084/jem.162.4.1193
42. Stebbins CC, Loss GE Jr, Elias CG, Chervonsky A, Sant AJ. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent. J Exp Med (1995) 184:1747-53.
43. Guagliardi LE, Koppelman B, Blum JS, Marks MS, Cresswell P, Brodsky FM. Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature (1990) 343:133-9. doi:10.1038/343133a0
44. Sanderson F, Kleijmeer MJ, Kelly A, Verwoerd D, Tulp A, Neefjes JJ, et al. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science (1994) 266:1566-9. doi:10.1126/science.7985027
45. Peters PJ, Raposo G, Neefjes JJ, Oorschot V, Leijendedder RL, Geuze HJ, et al. Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes. J Exp Med (1995) 182:325-34. doi:10.1084/jem.182.2.325
46. Kleijmeer MJ, Morkowski S, Griffith JM, Rudensky AY, Geuze HJ. Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J Cell Biol (1997) 139:639-49. doi:10.1083/jcb.139.3.639
47. Moore MW, Carbone FR, Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell (1988) 54:777-85. doi:10.1016/S0092-8674(88)91043-4
48. Yewdell JW, Bennink JR, Hosaka Y. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science (1988) 239:637-40. doi:10.1126/science.3257585
49. Powis SJ, Townsend ARM, Deverson EV, Bastin J, Butcher GW, Howard JC. Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature (1991) 354:528-31. doi:10.1038/354528a0
50. Spies T, Cerundolo V, Colonna M, Cresswell P, Townsend A, Demars R. Presentation of endogenous viral antigen by major histocompatibility class I molecules dependent on putative peptide transporter heterodimer. Nature (1992) 355:644-6. doi:10.1038/355644a0
51. Spies T, Cerundolo V, Colonna M, Cresswell P, Townsend A, Demars R. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature (1992) 355:644-6. doi:10.1038/355644a0
52. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell (1994) 78:761-71. doi:10.1016/S0092-8674(94)90462-6
53. Morrison LA, Lukacher AE, Braciale VL, Fan DP, Braciale TJ. Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J Exp Med (1986) 163:903-21. doi:10.1084/jem.163.4.903
54. Germain RN. The ins and outs of antigen processing and presentation. Nature (1986) 322:687-9. doi:10.1038/322687a0
55. Bevan MJ. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med (1976) 143:1283. doi:10.1084/jem.143.5.1283
56. Segura E, Villadangos JA. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells. Traffic (2011) 12:1677-85. doi:10.1111/j.1600-0854.2011.01254.x
57. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol (2005) 23:975-1028. doi:10.1146/annurev.immunol.22.012703.104538
58. Zhou F. Molecular mechanisms of viral immune evasion proteins to inhibit MHC class I antigen processing and presentation. Int Rev Immunol (2009) 28:376-93. doi:10.1080/08830180903013034
59. Lee P, Matsueda GR, Allen PM. T cell recognition of fibrinogen. A determinant on the Aα-chain does not require processing. J Immunol (1988) 140:1063-8.
60. Hampl J, Gradehandt G, Kalbacher H, Rude E. In vitro processing of insulin for recognition by murine T cells results in the generation of A chains with free CysSH. J Immunol (1992) 148:2664-71.
61. Accapezzato D, Nisini R, Paroli M, Bruno G, Bonino F, Houghton M, et al. Generation of an MHC class II-restricted T cell epitope by extracellular processing of hepatitis delta antigen. J Immunol (1998) 160:5262-6.
62. Santambrogio L, Sato AK, Carven GJ, Belyanskaya SL, Strominger JL, Stern LJ. Extracellular antigen processing and presentation by immature dendritic cells. Proc Natl Acad Sci U S A (1999) 96:15056-61. doi:10.1073/pnas.96.26.15056
63. Santambrogio L, Sato AK, Fischer FR, Dorf ME, Stern LJ. Abundant empty class II MHC molecules on the surface of immature dendritic cells. Proc Natl Acad Sci U S A (1999) 96:15050-5. doi:10.1073/pnas.96.26.15050
64. Rabinowitz JD, Vrljic M, Kasson PM, Liang MN, Busch R, Boniface JJ, et al. Formation of a highly peptide-receptive state of class II MHC. Immunity (1998) 9:699-709. doi:10.1016/S1074-7613(00)80667-6
65. Vacchino JF, McConnell HM. Peptide binding to active class II MHC protein on the cell surface. J Immunol (2001) 166:6680-5.
66. Venkatraman P, Nguyen TT, Sainlos M, Bilsel O, Chitta S, Imperiali B, et al. Fluorogenic probes for monitoring peptide binding to class II MHC proteins in living cells. Nat Chem Biol (2007) 3:222-8. doi:10.1038/nchembio868
67. Yuseff MI, Reversat A, Lankar D, Diaz J, Fanget I, Pierobon P, et al. Polarized secretion of lysosomes at the B cell synapse couples antigen extraction to processing and presentation. Immunity (2011) 35:361-74. doi:10.1016/j.immuni.2011.07.008
68. Adorini L, Apella E, Doria G, Cardinaux F, Nagy ZA. Competition for antigen presentation in living cells involves exchange of peptides bound by class II MHC molecules. Nature (1989) 342:800-3. doi:10.1038/342800a0
69. Harding CV, Roof RW, Unanue ER. Turnover of Ia-peptide complexes is facilitated in viable antigen-presenting cells: biosynthetic turnover of Ia vs. peptide exchange. Proc Natl Acad Sci U S A (1989) 86:4230-4. doi:10.1073/pnas.86.11.4230
70. Pinet V, Vergelli M, Martin R, Bakke O, Long EO. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature (1995) 375:603-6. doi:10.1038/375603a0
71. Chianese-Bullock KA, Russell HI, Moller C, Gerhard W, Monaco JJ, Eisenlohr LC. Antigen processing of two H2-IEd restricted epitopes is differentially influenced by the structural changes in a viral glycoprotein. J Immunol (1998) 161:1599-607.
72. Falnes PO, Sandvig K. Penetration of protein toxins into cells. Curr Opin Cell Biol (2000) 12:407-13. doi:10.1016/S0955-0674(00)00109-5
73. Sinnathamby G, Eisenlohr LC. Presentation by recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification. J Immunol (2003) 170:3504-13.
74. Martens S, McMahon HT. Mechanisms of membrane fusion: disparate players and common principles. Nat Rev Mol Cell Biol (2008) 9:543-56. doi:10.1038/nrm2417
75. Bikoff E, Bershtein BK. T cell clones specific for Ig G2a of the α allotype: direct evidence for presentation of endogenous antigen. J Immunol (1986) 137:28-34.
76. Bikoff EK, Eckhardt LA. Presentation of IgG2a antigens to class II-restricted T cells by stably transfected B lymphoma cells. Eur J Immunol (1989) 19:1903-9. doi:10.1002/eji.1830191022
77. Eisenlohr LC, Hackett CJ. Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. J Exp Med (1989) 169:921-31. doi:10.1084/jem.169.3.921
78. Weiss S, Bogen B. B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc Natl Acad Sci U S A (1989) 86:282-6. doi:10.1073/pnas.86.1.282
79. Weiss S, Bogen B. MHC class II-restricted presentation of intracellular antigen. Cell (1991) 64:767-76. doi:10.1016/0092-8674(91)90506-T
80. Loss GE Jr, Elias CG, Fields PE, Ribaudo RK, McKisic M, Sant AJ. Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways. J Exp Med (1993) 178:73-85. doi:10.1084/jem.178.1.73
81. Jacobson S, Sekaly RP, Bellini WJ, Johnson CL, McFarland HF, Long EO. Recognition of intracellular measles virus antigens by HLA class II restricted measles virus-specific cytotoxic T lymphocytes. Ann N Y Acad Sci (1988) 540:352-3. doi:10.1111/j.1749-6632.1988.tb27096.x
82. Jacobson S, Sekaly RP, Jacobson CL, McFarland HF, Long EO. HLA class II restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J Virol (1989) 63:1756-62.
83. Malnati MS, Marti M, Lavaute T, Jaraquemada D, Biddison W, Demars R, et al. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature (1992) 357:702-4. doi:10.1038/357702a0
84. Jaraquemada D, Marti M, Long EO. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II restricted T cells. J Exp Med (1990) 172:947-54. doi:10.1084/jem.172.3.947
85. Blum JS, Wearsch PA, Cresswell P. Pathways of antigen processing. Annu Rev Immunol (2013) 31:443-73. doi:10.1146/annurev-immunol-032712-095910
86. Eisenlohr LC. Alternative generation of MHC class II-restricted epitopes: not so exceptional? Mol Immunol (2013) 55:169-71. doi:10.1016/j.molimm.2012.10.020
87. Rudensky AY, Preston-Hulburt P, Hong S-C, Barlow A, Janeway CJ. Sequence analysis of peptides bound to MHC class II molecules. Nature (1991) 353:32767. doi:10.1038/353622a0
88. Yeager M, Carrington M, Hughes AL. Class I and class II MHC bind self peptide sets that are strikingly different in their evolutionary characteristics. Immunogenetics (2000) 51:8-15. doi:10.1007/s002510050002
89. Gannage M, Münz C. Autophagy in MHC class II presentation of endogenous antigens. Curr Top Microbiol Immunol (2009) 335:123-40. doi:10.1007/978-3-642-00302-8_6
90. Crotzer VL, Blum JS. Autophagy and adaptive immunity. Immunology (2010) 131:9-17. doi:10.1111/j.1365-2567.2010.03321.x
91. Sahu R, Kaushik S, Clement CC, Cannizzo ES, Scharf B, Follenzi A, et al. Microautophagy of cytosolic proteins by late endosomes. Dev Cell (2011) 20:131-9. doi:10.1016/j.devcel.2010.12.003
92. Mukherjee P, Dani A, Bhatia S, Singh N, Rudensky AY, George A, et al. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class ii is dependent on cytoplasmic proteolysis. J Immunol (2001) 167:2632-41.
93. Li P, Gregg JL, Wang N, Zhou D, O'Donnell P, Blum JS, et al. Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing. Immunol Rev (2005) 207:206-17. doi:10.1111/j.0105-2896.2005.00297.x
94. Tewari MK, Sinnathamby G, Rajagopal D, Eisenlohr LC. A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent. Nat Immunol (2005) 6:287-94. doi:10.1038/ni0405-420
95. Comber JD, Robinson TM, Siciliano NA, Snook AE, Eisenlohr LC. Functional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class II-restricted presentation. J Virol (2011) 85:6453-63. doi:10.1128/JVI.02122-10
96. Lechler R, Aichinger G, Lightstone L. The endogenous pathway of MHC class II antigen presentation. Immunol Rev (1996) 151:51-79. doi:10.1111/j.1600-065X.1996.tb00703.x
97. Mellins E, Smith L, Arp B, Cotner T, Celis E, Pious D. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature (1990) 343:71-4. doi:10.1038/343071a0
98. Paul P, Van Den Hoorn T, Jongsma ML, Bakker MJ, Hengeveld R, Janssen L, et al. A Genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation. Cell (2011) 145:268-83. doi:10.1016/j.cell.2011.03.023
99. Chesnut RW, Colon SM, Grey HM. Antigen presentation by normal B cells, B cell tumors, and macrophages: functional and biochemical comparison. J Immunol (1982) 128:1764-8.
100. Chesnut RW, Colon SM, Grey HM. Requirements for the processing of antigens by antigen-presenting B cells. I. Functional comparison of B cell tumors and macrophages. J Immunol (1982) 129:2382-8.
101. Grey HM, Colon SM, Chesnut RW. Requirements for the processing of antigen by antigen-presenting B cells. II. Biochemical comparison of the fate of antigen in B cell tumors and macrophages. J Immunol (1982) 129:2389-95.
102. Guidos C, Wong M, Lee K-C. A comparison of the stimulatory activities of lymphoid dendritic cells and macrophages in T proliferative responses to various antigens. J Immunol (1984) 133:1179-84.
103. Lee KC, Guidos C. Heterogeneity of macrophages and dendritic cells as accessory cells. Immunobiology (1984) 168:172-81. doi:10.1016/S0171-2985(84)80108-4
104. Bjercke S, Gaudernack G. Dendritic cells and monocytes as accessory cells in T-cell responses in man. II. Function as antigen-presenting cells. Scand J Immunol (1985) 21:501-8. doi:10.1111/j.1365-3083.1985.tb01839.x
105. Scheerlinck JP, Burssens G, Brys L, Michel A, Hauser P, De Baetselier P. Differential presentation of hepatitis B S-preS(2) particles and peptides by macrophages and B-cell like antigen-presenting cells. Immunology (1991) 73:88-94.
106. Garrigan K, Moroni-Rawson P, McMurray C, Hermans I, Abernethy N, Watson J, et al. Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors. Blood (1996) 88:3508-12.
107. Milich DR, Chen M, Schodel F, Peterson DL, Jones JE, Hughes JL. Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci U S A (1997) 94:14648-53. doi:10.1073/pnas.94.26.14648
108. Gluckman JC, Canque B, Rosenzwajg M. Dendritic cells: a complex cellular system. Transfus Clin Biol (1998) 5:47-55. doi:10.1016/S1246-7820(98)80110-9
109. Lennon-Dumenil AM, Bakker AH, Wolf-Bryant P, Ploegh HL, Lagaudriere-Gesbert C. A closer look at proteolysis and MHC-class-II-restricted antigen presentation. Curr Opin Immunol (2002) 14:15-21. doi:10.1016/S0952-7915(01)00293-X
110. Holmdahl M, Grubb A, Holmdahl R. Cysteine proteases in Langerhans cells limits presentation of cartilage derived type II collagen for autoreactive T cells. Int Immunol (2004) 16:717-26. doi:10.1093/intimm/dxh079
111. Pereira SR, Faca VM, Gomes GG, Chammas R, Fontes AM, Covas DT, et al. Changes in the proteomic profile during differentiation and maturation of human monocyte-derived dendritic cells stimulated with granulocyte macrophage colony stimulating factor/interleukin-4 and lipopolysaccharide. Proteomics (2005) 5:1186-98. doi:10.1002/pmic.200400988
112. Duclos S, Clavarino G, Rousserie G, Goyette G, Boulais J, Camossetto V, et al. The endosomal proteome of macrophage and dendritic cells. Proteomics (2011) 11:854-64. doi:10.1002/pmic.201000577
113. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med (2000) 191:1499-512. doi:10.1084/jem.191.9.1499
114. Shoukry NH, Cawthon AG, Walker CM. Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu Rev Microbiol (2004) 58:391-424. doi:10.1146/annurev.micro.58.030603.123836
115. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med (2012) 18:274-80. doi:10.1038/nm.2612
116. Zhou Y, Callendret B, Xu D, Brasky KM, Feng Z, Hensley LL, et al. Dominance of the CD4+ T helper cell response during acute resolving hepatitis A virus infection. J Exp Med (2012) 209:1481-92. doi:10.1084/jem.20111906
117. Koch R. Mittheilungen über ein Heilmittel gegen Tuberculose. Dt med Wochenschr (1891) 17:101-2. doi:10.1055/s-0029-1206198
118. Dienes L, Schoenheit EW. The reproduction of tuberculin hypersensitiveness in guinea pigs with various protein substances. Am Rev Tubercul (1929) 20:92-105.
119. Gorer P. The genetic and antigenic basis of tumor transplantation. J Pathol Bacteriol (1937) 44:691-7. doi:10.1002/path.1700440313
120. Gell PG, Hinde IT. The histology of the tuberculin reaction and its modification by cortisone. Br J Exp Pathol (1951) 32:516-29.
121. Claman HN, Chaperon EA, Triplett RF. Thymus-marrow cell combinations. Synergism in antibody production. Proc Soc Exp Biol Med (1966) 122:1167-71. doi:10.3181/00379727-122-31353
122. Rosenthal AS, Shevach EM. Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes. J Exp Med (1973) 138:1194-212. doi:10.1084/jem.138.5.1194
123. Jones PP, Murphy DB, Hewgill D, McDevitt HO. Detection of a common polypeptide chain in I-A and I-E sub-region immunoprecipitates. Mol Immunol (1979) 16:51-60. doi:10.1016/0161-5890(79)90027-0
124. Nussenzweig MC, Steinman RM, Gutchinov B, Cohn ZA. Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes. J Exp Med (1980) 152:1070-84. doi:10.1084/jem.152.4.1070
125. Steinman RM, Nussenzweig MC. Dendritic cells: features and functions. Immunol Rev (1980) 53:125-47. doi:10.1111/j.1600-065X.1980.tb01042.x
126. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med (1973) 137:1142-62. doi:10.1084/jem.137.5.1142
127. Brown JH, Jardetsky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature (1993) 364:33-9. doi:10.1038/364033a0
128. Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P. HLA-DR Molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature (1992) 360:474-6. doi:10.1038/360474a0
129. Denzin LK, Sant'angelo DB, Hammond C, Surman MJ, Cresswell P. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science (1997) 278:106-9. doi:10.1126/science.278.5335.106
130. Pos W, Sethi DK, Call MJ, Schulze MS, Anders AK, Pyrdol J, et al. Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection. Cell (2012) 151:1557-68. doi:10.1016/j.cell.2012.11.025
131. Guce AI, Mortimer SE, Yoon T, Painter CA, Jiang W, Mellins ED, et al. HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism. Nat Struct Mol Biol (2013) 20:90-8. doi:10.1038/nsmb.2460
132. Govaerts A. Cellular antibodies in kidney homotransplantation. J Immunol (1960) 85:516-22.
133. Lundstedt C. Interaction between antigenically different cells. Virus-induced cytotoxicity by immune lymphoid cells in vitro. Acta Pathol Microbiol Scand (1969) 75:139-52.
134. Zinkernagel RM, Doherty PC. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature (1974) 248:701-2. doi:10.1038/248701a0
135. Townsend ARM, Gotch FM, Davey J. Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell (1985) 42:457-67. doi:10.1016/0092-8674(85)90103-5
136. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature (1987) 329:506-12. doi:10.1038/329506a0
137. Falk K, Rötzschke O, Rammensee H-G. Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature (1990) 348:248-51. doi:10.1038/348248a0
138. Rötzschke O, Falk K, Deres K, Schild H, Norda M, Metzger J, et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature (1990) 348:252-4. doi:10.1038/348252a0
139. Van Bleek GM, Nathenson SG. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature (1990) 348:213-6. doi:10.1038/348213a0
140. Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci U S A (1993) 90:4942-6. doi:10.1073/pnas.90.11.4942
141. Sadasivan B, Lahner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity (1996) 5:103-14. doi:10.1016/S1074-7613(00)80487-2
142. Reits EA, Vos JC, Gromme M, Neefjes J. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature (2000) 404:774-8. doi:10.1038/35008103
143. Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature (2000) 404:770-4. doi:10.1038/35008096
144. Brouwenstijn N, Serwold T, Shastri N. MHC class I molecules can direct proteolytic cleavage of antigenic precursors in the endoplasmic reticulum. Immunity (2001) 15:95-104. doi:10.1016/S1074-7613(01)00174-1
145. Serwold T, Gaw S, Shastri N. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat Immunol (2001) 2:644-51. doi:10.1038/89800
146. Brazil MI, Weiss S, Stockinger B. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules. Eur J Immunol (1997) 27:1506-14. doi:10.1002/eji.1830270629
147. Zhou D, Li P, Lin Y, Lott JM, Hislop AD, Canaday DH, et al. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity (2005) 22:571-81. doi:10.1016/j.immuni.2005.03.009